Fundraising Fox

Perlara

YC W16 ↗

San Francisco, US · Founded 2014 · Delaware corporation · 1 employees · 1 known investors

perlara.com ↗

Perlara is a biopharmaceutical company that develops treatments for ultra-rare genetic diseases using yeast-based disease modeling and drug repurposing strategies. The company operates as a full-stack drug development platform serving rare disease patients and families.

BiotechDeep TechHealthtechMedical Devicesin /company@perlarapbcycombinator.com ↗

Founders & leadership· Y Combinator alumni (W16)

EP
Ethan PerlsteinCEO and founder
MW
Matthew WilseyDirector
LA
Linda AveyDirector

Investors · 1

Y CombinatorSan Francisco · $500K

Reported raises · per SEC filings

Form D private placements
▶$4.1MraisedAug 2017 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ethan O PerlsteinExecutive Officer, Director, Promoter
  • Matthew WilseyDirector
  • Linda AveyDirector
Offering amount
$7.4M
Amount sold
$4.1M
First sale
Aug 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news